Bibliography
- Doggrell SA. The failure of torcetrapib: is there a case for independent preclinical and clinical testing. Expert Opin Pharmacother 2008;9:875-878
- Tardif JC, Heinonen T, Orloff D, Libby P. Vascular biomarkers and surrogates in cardiovascular disease. Circulation 2006;113:2936-42
- Avorn J. Torcetrapib and Atorvastatin – Should Marketing Drive the Research Agenda? N Engl J Med 2005;352:2573-6
- Shear CL. Torcetrapib and Atorvastatin [letter]. N Engl J Med 2005;353:1527
- Barter P, Caulfield M, Eriksson M, et al. Effects of torcetrapib on morbidity and mortality in the ILLUMINATE trial. N Engl J Med 2007;357:2109-22
- DePasquale M, Knight D, Loging W, et al. Mechanistic studies of hemodynamics with a series of cholesterol ester transfer protein inhibitors [abstract 4021]. Circ Res 2007;101(11):1209-10